share_log

This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

這位分析師以看好的態度開始覆蓋;以下是週三的五大啓動策略
Benzinga ·  10:03

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

華爾街頂級分析師改變了對這些知名人士的看法。要全面了解所有分析師評級變動,包括上調和降級,請參閱我們的分析師評級頁面。

  • Goldman Sachs analyst Paul Choi initiated coverage on Lantheus Holdings, Inc. (NASDAQ:LNTH) with a Buy rating and announced a price target of $143. Lantheus shares closed at $92.66 on Tuesday. See how other analysts view this stock.
  • DA Davidson analyst Lucky Schreiner initiated coverage on Box, Inc (NYSE:BOX) with a Buy rating and announced a price target of $45. Box shares closed at $32.07 on Tuesday. See how other analysts view this stock.
  • Brookline Capital analyst Kumaraguru Raja initiated coverage on Quince Therapeutics, Inc. (NASDAQ:QNCX) with a Buy rating and announced a price target of $9. Quince Therapeutics shares closed at $1.84 on Tuesday. See how other analysts view this stock.
  • B of A Securities analyst Tazeen Ahmad initiated coverage on KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) with a Buy rating and announced a price target of $22. KalVista Pharma shares closed at $8.65 on Tuesday. See how other analysts view this stock.
  • Raymond James analyst Andrew Marok initiated coverage on DoubleVerify Holdings, Inc. (NYSE:DV) with an Outperform rating and announced a price target of $25. Fluor shares closed at $19.95 on Tuesday. See how other analysts view this stock.
  • 高盛分析師保羅·崔以買入評級啓動了對蘭修斯控股公司(納斯達克股票代碼:LNTH)的報道,並宣佈目標股價爲143美元。蘭修斯股價週二收於92.66美元。看看其他分析師如何看待這隻股票。
  • DA Davidson分析師Lucky Schreiner以買入評級啓動了對Box, Inc(紐約證券交易所代碼:BOX)的報道,並宣佈目標股價爲45美元。Box股價週二收於32.07美元。看看其他分析師如何看待這隻股票。
  • 布魯克林資本分析師庫馬拉古魯·拉賈以買入評級啓動了對昆斯療法公司(納斯達克股票代碼:QNCX)的報道,並宣佈目標股價爲9美元。Quince Therapeutics股價週二收於1.84美元。看看其他分析師如何看待這隻股票。
  • b of A 證券分析師塔澤恩·艾哈邁德開始對KalVista Pharmicals, Inc.(納斯達克股票代碼:KALV)進行報道,評級爲買入,並宣佈目標股價爲22美元。週二,KalVista Pharma股價收於8.65美元。看看其他分析師如何看待這隻股票。
  • 雷蒙德·詹姆斯分析師安德魯·馬洛克以跑贏大盤的評級開始了對DoubleVerify Holdings, Inc.(紐約證券交易所代碼:DV)的報道,並宣佈目標股價爲25美元。福陸股價週二收於19.95美元。看看其他分析師如何看待這隻股票。

Considering buying BOX stock? Here's what analysts think:

考慮購買 BOX 股票?以下是分析師的想法:

big

Read This Next:

接下來閱讀這篇文章:

  • Top 3 Health Care Stocks That May Explode In Q4
  • 第四季度可能爆發的三大醫療保健股
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論